DEVELOPMENT OF NOVEL, NON-TOXIC RIFAMYCINS THAT REVERSE...

Hematological Oncology 2017 / 06 Vol. 35

DEVELOPMENT OF NOVEL, NON-TOXIC RIFAMYCINS THAT REVERSE DRUG RESISTANCE IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

Maxwell, S.A., Wallis, D., Zhou, N., Baker, D., Mousavi-Fard, S., Loesch, K., Galaviz, S., Sun, Q., Threadgill, D.M., Rojas, C.M., O'Brien, M., Clubb, F.J., Ioerger, T., DeJesus, M., Dong, W., Seemann
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_118
Date:
June, 2017
File:
PDF, 90 KB
english, 2017
Conversion to is in progress
Conversion to is failed